SCHLIEREN, Switzerland and SAN FRANCISCO, Oct. 3, 2019 /PRNewswire/ -- Akero Therapeutics and InSphero AG today announced that Akero has selected InSphero's 3D InSight™ Human Liver Disease Platform to ...
SCHLIEREN, ZURICH, SWITZERLAND, February 11, 2026 /EINPresswire.com/ — InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results